Medical Research & Technology

Minneapolis – September 15, 2026 -- A new study suggests one simple screen protector swap could ease digital eye strain for iPhone users, just as Apple's latest lineup hits shelves. Eyesafe, a screen-health technology company, published a white paper detailing survey results from 29 adult iPhone users conducted with Southwest Eye Care, an eye clinic.

Participants chose Eyesafe's filter nearly six times more often than a standard protector

In the two-period study, each participant used their phone at least two hours daily. They wore a standard clear screen protector for two weeks, then switched to one with Eyesafe CPF70 Technology for two weeks, completing identical surveys after each phase. Overall, 62% preferred the CPF70 protector, compared with 10% who preferred the standard one; 28% reported no preference.

Boise, Idaho – September 15, 2026 -- Cobblestone Car Wash is donating $1 from every GrapheneX Express Exterior wash purchased at any of its Idaho locations throughout September to St. Luke's Children's Hospital's pediatric cancer research program.

The initiative coincides with Childhood Cancer Awareness Month and applies to all 14 Cobblestone locations across Idaho.

Roughly 15,000 children are diagnosed with cancer annually in the US

Cobblestone and St. Luke's Children's Hospital cite this figure as the basis for the campaign, which aims to fund improved treatment options, new therapy development, survivorship care, and reduced disparities in pediatric cancer outcomes.

Customers simply upgrade their wash to trigger the donation

Any driver who selects the GrapheneX Express Exterior wash at a participating Idaho location during September automatically generates the $1 donation, with no additional steps required.

New York – September 13, 2026 -- Elysium Health has opened The Elysium Longevity Institute (TELI), a physician-led longevity medicine program now available to eligible patients across the United States.

Eighteen protocols combine prescription drugs, peptides and supplements

At launch, TELI offers 18 longevity-focused protocols delivered in oral, intranasal and injectable forms, including prescription medications, peptides, supplements and vitamins. Patients begin with a comprehensive medical intake, after which licensed providers build individualized treatment plans based on medical history, lifestyle and health goals. Protocols are adjusted over time as a patient's health or objectives change, with ongoing clinical support built into the program.

Chicago – September 13, 2026 -- The American Lung Association is expanding its Awareness, Trust and Action campaign to encourage more lung cancer patients to ask their doctors about clinical trials as a treatment option.

Every current lung cancer treatment originated in a clinical trial

"Clinical trials provide the most promising way to improve treatment outcomes and continue advancements in lung cancer care and survivorship," said Harold Wimmer, President and CEO of the American Lung Association. He said the organization wants patients and caregivers to discuss all treatment options, including trials, with their healthcare providers.

Scottsdale, Ariz. – September 12, 2026 -- An FDA advisory panel voted 8-6-1 in July 2026 to recommend adding BPC-157 free base and BPC-157 acetate to the Section 503A Bulks List, a move that would let pharmacies compound the peptide more broadly if finalized. The vote does not make BPC-157 FDA-approved, and the recommendation is non-binding.

FDA staff had opposed adding BPC-157 to the list

According to FDA materials reviewed by telehealth company Promise, agency review staff proposed against including either form of BPC-157 before the July 23, 2026 committee meeting. The favorable vote reflects a split between committee members and FDA staff, not an agency endorsement. FDA's briefing document notes that neither form of BPC-157 has an applicable USP/NF drug-substance monograph, and neither is a component of an already-approved drug.

Little Rock – September 12, 2026 -- The American Association of Kidney Patients (AAKP) will host its 51st annual National Patient Meeting September 10-13, 2026, in Little Rock, Arkansas, with free admission and meals for kidney patients, family members, care partners, and living organ donors. Pre-registration is encouraged online or by calling (800) 749-2257.

The event opens with a free policy forum at the Clinton Presidential Center

AAKP's Public Policy Forum runs September 10 from 1:00 p.m. to 4:00 p.m. CT at the William J. Clinton Presidential Center, with doors opening at noon and lunch provided. The session covers kidney research, innovation, and how federal regulatory and reimbursement decisions affect patient care. Registration is required.

Irving, Texas – September 11, 2026 -- Caris Life Sciences has launched a national awareness campaign called "Math," featuring actor Kevin Costner, to promote Caris Detect, a multi-cancer early detection blood test now available across the United States.

The blood test screens for cancer signals before symptoms appear

Caris Detect combines ultra-deep Whole Genome Sequencing, Whole Transcriptome Sequencing, and artificial intelligence to scan the bloodstream for molecular signals associated with cancer. Unlike tests that check only a limited set of biomarkers, the company says its approach analyzes the entire genome and transcriptome for a broader molecular picture. The test is designed to complement, not replace, routine cancer screenings.

Berlin – September 11, 2026 -- Diabetes can silently damage the eyes years before patients notice any change in their vision, yet new data show barely half of people with type 2 diabetes get the recommended eye exam. To close that gap, German health insurer mkk - meine krankenkasse now offers its members a free eye screening from Skleo Health at participating opticians and drugstores.

About seven million adults in Germany live with known or undiagnosed diabetes, according to the Robert Koch Institute. One serious complication is diabetic retinopathy, damage to the tiny blood vessels in the retina caused by diabetes duration, high blood sugar, and hypertension. Retinal changes can develop long before someone experiences blurred vision or other symptoms.

Munich – September 09, 2026 -- A new two-part investigative docuseries, "Seelenfänger: Der falsche Heiler," premieres October 13, 2026 in the ARD Mediathek and airs October 19, 2026 at 11:30 p.m. on BR Fernsehen, documenting families who lost loved ones after they trusted the pseudo-medical theory known as "Germanische Neue Medizin" (Germanic New Medicine).

The theory rejects evidence-based cancer treatment

Germanic New Medicine frames cancer not as a disease but as the physical manifestation of an unresolved psychological conflict. Followers of the theory are encouraged to reject conventional, evidence-based medical treatment -- a choice the docuseries links directly to preventable deaths.

Somerset, N.J. – September 08, 2026 -- A prostate cancer specialist with more than 30 years of experience says his own diagnosis nearly slipped through the cracks despite a PSA reading that looked normal, a warning he's sharing as ProCure Proton Therapy Center marks National Prostate Cancer Awareness Month.

Dr. Edward Soffen said his PSA level was actually slightly lower than it had been six months earlier when his urologist flagged the result as 'labile,' meaning it fluctuates. That prompted a urine DNA test, which showed a 50 percent malignancy risk. A follow-up MRI and biopsy confirmed cancer.

A PSA under 4 ng/mL doesn't rule out cancer

Dr. Soffen said men with PSA readings in the 'normal' range, under 4 ng/mL, should still report any fluctuation to their doctor and ask about additional testing that can catch cancers PSA alone might miss.